BOOK
The Neuro-Ophthalmology Survival Guide E-Book
Anthony Pane | Neil R. Miller | Mike Burdon
(2017)
Additional Information
Book Details
Abstract
This book is a practical, symptom-based, ‘how-to’ guide to neuro-ophthalmology and acquired strabismus for all trainee and practising ophthalmologists and optometrists. Each chapter focusses on a specific clinical symptom and includes an introduction to the clinical assessment of a symptom; an examination checklist; a management flowchart to be followed; clinical diagnostic criteria checklists; and further information on the diseases that can cause the symptom with a brief discussion of appropriate management.
- A practical and accessible handbook for the ophthalmologist or optometrist without a specialist interest in neuro-ophthalmology and acquired strabismus.
- The text simplifies a subject which is often a cause of litigation against practising ophthalmologists and exam failure for trainees and residents.
- The book aids diagnosis in a field in which mistakes may lead to medico-legal problems, e.g. brain tumours presenting with blurred or double vision.
- The book leads the reader from the symptom, through a series of simple but safe flowcharts and check-lists, to the diagnosis or the tests which need to be ordered.
- The first chapter presents 20 ‘golden rules’ to keep you and your patients out of trouble.
- A revised text with some new illustrations brings this highly-praised book up to date.
- New online videos demonstrate abnormal eye movements, eyelid problems and pupil abnormalities.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Inside Front Cover | ifc1 | ||
The Neuro-ophthalmology Survival Guide | i | ||
Copyright Page | iv | ||
Table Of Contents | v | ||
Video contents | vi | ||
Preface | ix | ||
Index of key management flowcharts | xi | ||
Index of key clinical diagnostic criteria | xii | ||
Introduction | 1 | ||
1. You can’t avoid neuro-ophthalmology! | 1 | ||
2. Neuro-ophthalmology is special! | 1 | ||
3. You want your patients to see well! | 1 | ||
4. You want your patients to stay healthy! | 1 | ||
5. You want to stay out of trouble! | 2 | ||
6. You want to pass your exam (if you still have it ahead of you) | 2 | ||
How can this book help? | 2 | ||
1 Staying out of trouble | 5 | ||
Contents | 5 | ||
Twenty neuro “rules” to keep you out of trouble | 5 | ||
Patient presentation | 6 | ||
Examination | 7 | ||
Blurred vision or field loss | 8 | ||
Bilateral disc swelling | 15 | ||
Double vision | 17 | ||
Giant cell arteritis (GCA) | 22 | ||
Neuro-imaging | 23 | ||
Ophthalmic emergencies | 24 | ||
Three common mistakes | 25 | ||
2 Blurred vision or field loss | 27 | ||
Contents | 27 | ||
Introduction | 28 | ||
Eye disease | 28 | ||
Optic nerve disease | 28 | ||
Optic chiasmal disease | 29 | ||
Retrochiasmal disease | 29 | ||
Non-organic visual loss | 29 | ||
Examination checklist | 29 | ||
Blurred vision or field loss | 29 | ||
History | 29 | ||
Examination | 30 | ||
Plus: must perform some type of perimetry: | 30 | ||
Management flowchart | 31 | ||
Blurred vision or field loss NOT explained by visible ocular disease | 31 | ||
Optic neuropathy | 39 | ||
Acute optic neuropathies 40 | 39 | ||
Chronic optic neuropathies 68 | 39 | ||
Optic neuropathy that cannot be diagnosed clinically | 39 | ||
Acute optic neuropathies | 40 | ||
Typical optic neuritis | 40 | ||
Demographic | 40 | ||
Symptoms | 40 | ||
Ophthalmic | 40 | ||
Neurologic | 40 | ||
Signs | 41 | ||
Differential diagnosis | 42 | ||
Investigations | 42 | ||
Visual prognosis | 42 | ||
Treatment for the visual loss of typical optic neuritis | 42 | ||
Systemic prognosis: relationship of typical optic neuritis to multiple sclerosis | 43 | ||
Treatment to delay development of MS | 43 | ||
Corticosteroids: | 43 | ||
Disease-modifying treatments for MS | 43 | ||
Management recommendations | 44 | ||
Anterior ischemic optic neuropathy (AION) | 44 | ||
Causes | 44 | ||
Risk factors | 45 | ||
Arteritic AION | 45 | ||
Non-arteritic AION | 45 | ||
Symptoms | 45 | ||
Signs | 45 | ||
Differential diagnosis | 46 | ||
Investigations | 46 | ||
Distinguishing between arteritic and non-arteritic AION | 46 | ||
Symptoms suggesting GCA | 46 | ||
Signs suggesting GCA | 46 | ||
Blood test results suggesting GCA | 48 | ||
Investigation and treatment of suspected arteritic AION (AION due to GCA) | 48 | ||
Referral | 48 | ||
Initial treatment | 48 | ||
Temporal artery biopsy | 49 | ||
Further treatment and follow-up | 49 | ||
Visual prognosis | 50 | ||
Investigation, treatment and prognosis of non-arteritic AION | 50 | ||
Investigations | 50 | ||
Treatment | 51 | ||
Follow-up | 52 | ||
Prognosis | 52 | ||
Note: “diabetic papillopathy” | 52 | ||
Traumatic optic neuropathy | 53 | ||
Mechanism | 53 | ||
Symptoms | 53 | ||
Signs | 53 | ||
Investigations | 53 | ||
Treatment | 54 | ||
Neuromyelitis optica (NMO) | 54 | ||
Demographic | 55 | ||
Symptoms | 55 | ||
Signs | 55 | ||
Differential diagnosis | 55 | ||
Investigations | 55 | ||
Summary: suspect NMO if a patient with optic neuritis has: | 56 | ||
Prognosis | 57 | ||
Treatment | 57 | ||
Anti-MOG antibody-related optic neuritis | 57 | ||
Infectious optic neuritis | 57 | ||
Causes | 57 | ||
Symptoms | 58 | ||
Signs | 58 | ||
3 Swollen disc/s, normal vision | 107 | ||
Contents | 107 | ||
Introduction | 108 | ||
Examination checklist | 108 | ||
Swollen disc/s, normal vision | 108 | ||
History | 108 | ||
Examination | 109 | ||
Plus: perform perimetry: | 109 | ||
Management flowchart | 110 | ||
Swollen disc/s, normal vision | 110 | ||
Disc pseudo-swelling | 114 | ||
Definition | 114 | ||
Causes | 114 | ||
Characteristics | 116 | ||
Spontaneous venous pulsations (SVPs) | 116 | ||
Differentiation from true disc swelling | 116 | ||
Investigations to help determine if pseudo- or true swelling is present | 117 | ||
True disc swelling | 119 | ||
Suggested investigations for swollen disc/s with normal vision | 119 | ||
1. Review history, examination and perimetry | 119 | ||
2. Urgent (same-day) MRI of optic nerves and brain with contrast, plus MRV brain, or CT brain and CTV | 120 | ||
3. Lumbar puncture if MRI and MRV or CT and CTV are normal | 120 | ||
4. Other investigations in ALL patients | 121 | ||
Blood tests | 121 | ||
Chest x-ray and/or chest CT scan | 122 | ||
Eye disease | 122 | ||
Optic nerve disease | 123 | ||
Early or mild optic neuropathy | 123 | ||
Optic perineuritis | 123 | ||
Blood disease | 124 | ||
Blood pressure: severe hypertension | 124 | ||
Blood glucose: diabetic papillopathy | 124 | ||
Blood electrolyte disturbance | 125 | ||
Papilledema | 125 | ||
Definition | 125 | ||
Causes | 125 | ||
Mechanism | 126 | ||
Incidence and clinical interpretation | 127 | ||
Not all patients with raised intracranial pressure develop papilledema | 127 | ||
The severity of disc swelling in papilledema does not necessarily correlate with the level of intracranial pressure | 127 | ||
“Dead discs can’t swell” | 127 | ||
Timecourse | 127 | ||
Symptoms | 127 | ||
Neurologic symptoms | 128 | ||
Ophthalmic symptoms | 128 | ||
Signs | 128 | ||
Disc appearance | 129 | ||
Complications | 131 | ||
Neurologic | 131 | ||
Ophthalmic | 131 | ||
Differential diagnosis | 132 | ||
Investigations | 132 | ||
Treatment | 132 | ||
Diseases that can cause papilledema | 133 | ||
Brain tumors | 133 | ||
Demographic | 133 | ||
Mechanism | 133 | ||
Symptoms | 133 | ||
Signs | 134 | ||
Investigations | 134 | ||
Treatment | 134 | ||
Hydrocephalus | 135 | ||
Definition | 135 | ||
Demographic | 135 | ||
Mechanism and types | 135 | ||
Symptoms | 135 | ||
Signs | 135 | ||
Investigations | 135 | ||
Treatment | 136 | ||
Meningitis | 136 | ||
Causes | 136 | ||
Mechanism | 136 | ||
Symptoms | 136 | ||
Signs | 136 | ||
Investigations | 136 | ||
Treatment | 137 | ||
Dural venous sinus thrombosis | 137 | ||
Demographic | 137 | ||
Mechanism | 137 | ||
Causes | 137 | ||
Symptoms | 138 | ||
Signs | 138 | ||
Investigations | 138 | ||
Treatment | 138 | ||
Extracranial venous outflow obstruction | 139 | ||
Mechanism | 139 | ||
Causes | 139 | ||
Symptoms and signs | 139 | ||
Investigations | 139 | ||
Treatment | 139 | ||
Secondary pseudotumor cerebri syndrome (pseudotumor cerebri of known cause other than obesity) | 139 | ||
Definition | 139 | ||
Demographic | 141 | ||
Mechanism | 141 | ||
Possible causes | 141 | ||
Symptoms and signs | 141 | ||
Investigations | 141 | ||
Treatment | 142 | ||
Idiopathic intracranial hypertension (IIH; also known as primary pseudotumor cerebri syndrome) associated with obesity | 142 | ||
Definition | 142 | ||
Terminology | 143 | ||
Demographic | 143 | ||
Mechanism | 144 | ||
Symptoms | 144 | ||
Signs | 144 | ||
Complications | 144 | ||
Differential diagnosis | 146 | ||
Investigations | 146 | ||
Treatment | 146 | ||
Observation without treatment other than weight loss | 146 | ||
Weight loss | 147 | ||
Medical treatment | 147 | ||
Oral acetazolamide (Diamox) | 147 | ||
Oral diuretics | 148 | ||
Oral topiramate (Topamax) | 148 | ||
Surgical treatment | 149 | ||
Follow-up | 150 | ||
4 Transient visual loss | 151 | ||
Contents | 151 | ||
Introduction | 152 | ||
Monocular transient visual loss | 152 | ||
Binocular transient visual loss | 153 | ||
Examination checklist | 153 | ||
Transient visual loss | 153 | ||
History | 153 | ||
Examination | 154 | ||
Plus: perform perimetry: | 154 | ||
Management flowchart | 155 | ||
Transient visual loss | 155 | ||
Monocular transient visual loss | 159 | ||
Binocular visual loss mistakenly attributed to one eye | 159 | ||
Eye disease | 159 | ||
Optic nerve disease | 160 | ||
Vascular disease | 160 | ||
Giant cell arteritis (GCA) | 160 | ||
Ocular ischemic syndrome | 161 | ||
Symptoms | 161 | ||
Signs | 161 | ||
Investigations | 161 | ||
Treatment | 161 | ||
Embolic monocular transient visual loss (“amaurosis fugax”) | 162 | ||
Causes | 162 | ||
Symptoms | 162 | ||
Signs | 162 | ||
Investigations | 162 | ||
Treatment | 163 | ||
Vasospastic monocular transient visual loss (“retinal migraine”) | 163 | ||
Symptoms | 164 | ||
Signs | 164 | ||
Investigations and treatment | 164 | ||
Binocular transient visual loss | 164 | ||
Monocular visual loss mistakenly attributed to both eyes | 164 | ||
Bilateral simultaneous eye or optic nerve disease | 164 | ||
Retrochiasmal disease | 164 | ||
Seizure activity from a tumor or arteriovenous malformation (AVM) | 164 | ||
Migraine | 165 | ||
Mechanism | 165 | ||
Symptoms | 165 | ||
Signs | 166 | ||
Investigations | 166 | ||
Treatment | 166 | ||
Vascular disease | 167 | ||
Giant cell arteritis | 167 | ||
Vertebrobasilar insufficiency | 167 | ||
Mechanism | 167 | ||
Causes | 167 | ||
Symptoms | 167 | ||
Signs | 168 | ||
Investigations | 168 | ||
Treatment | 168 | ||
5 Double vision | 169 | ||
Contents | 169 | ||
Introduction | 170 | ||
Eye disease | 170 | ||
Orbit or extraocular muscle disease | 171 | ||
Neuromuscular junction disease | 171 | ||
Ocular motor nerve disease | 171 | ||
Brain disease | 171 | ||
Examination checklist | 172 | ||
Diplopia | 172 | ||
History | 172 | ||
Examination | 172 | ||
Plus: perform perimetry if: | 173 | ||
Management flowchart | 174 | ||
Double vision | 174 | ||
Monocular diplopia | 185 | ||
Causes | 185 | ||
Symptoms | 185 | ||
Signs | 186 | ||
Investigations and treatment | 186 | ||
Binocular diplopia | 186 | ||
Muscle or orbit disease | 186 | ||
Restrictive myopathy | 186 | ||
Causes | 186 | ||
Symptoms | 187 | ||
Signs | 187 | ||
Investigations | 187 | ||
Treatment | 188 | ||
Paretic myopathy | 188 | ||
Causes | 188 | ||
Symptoms | 188 | ||
Signs | 188 | ||
Investigations | 188 | ||
Treatment | 189 | ||
Acute orbitopathy | 189 | ||
Causes | 190 | ||
Symptoms | 190 | ||
Signs | 190 | ||
Investigations | 192 | ||
Treatment | 193 | ||
Neuromuscular junction disease | 193 | ||
Myasthenia gravis | 193 | ||
Mechanism | 193 | ||
Causes | 193 | ||
Symptoms | 193 | ||
Diplopia | 194 | ||
Ptosis | 194 | ||
Systemic symptoms | 194 | ||
Signs | 194 | ||
Abnormal ocular motility (Figs. 5.5 and 5.6, Videos 5.3 and 5.4) | 194 | ||
Ptosis (see also Chapter 10, p. 300) | 196 | ||
Other ophthalmic signs of myasthenia | 196 | ||
Systemic signs | 197 | ||
Clinical tests | 197 | ||
Sleep/rest test | 197 | ||
Ice test | 197 | ||
Tensilon test | 197 | ||
Prostigmin test | 199 | ||
Investigations | 199 | ||
Natural history | 200 | ||
Treatment | 200 | ||
Optical treatment | 200 | ||
Medical treatment | 200 | ||
Surgical treatment | 201 | ||
Nerve disease | 201 | ||
Third nerve palsy | 201 | ||
Causes | 201 | ||
Symptoms | 202 | ||
Signs | 202 | ||
Partial third nerve palsy (Figs. 5.8 and 5.9, Videos 5.5–5.8) | 204 | ||
Complete third nerve palsy (Fig. 5.10, Video 5.9) | 206 | ||
“Pupil-sparing” third nerve palsy (Fig. 5.11, Video 5.10) | 207 | ||
Differential diagnosis | 208 | ||
Investigations | 208 | ||
Treatment | 208 | ||
Fourth nerve palsy | 209 | ||
Causes | 210 | ||
Symptoms and signs | 210 | ||
Acquired unilateral fourth nerve palsy (Fig. 5.14, Video 5.11) | 212 | ||
Acquired bilateral fourth nerve palsy | 213 | ||
Congenital unilateral fourth nerve palsy (Fig. 5.15, Video 5.12) | 213 | ||
Differential diagnosis | 213 | ||
Investigations | 215 | ||
Treatment | 215 | ||
Sixth nerve palsy | 215 | ||
Causes | 216 | ||
Symptoms | 216 | ||
Signs | 217 | ||
Differential diagnosis | 217 | ||
Investigations | 220 | ||
Treatment | 220 | ||
Unilateral multiple nerve palsies | 221 | ||
Cavernous sinus syndrome | 221 | ||
Causes | 222 | ||
Symptoms | 222 | ||
Signs (Video 5.14) | 222 | ||
Investigations | 222 | ||
Treatment | 222 | ||
Orbital apex syndrome | 223 | ||
Bilateral multiple nerve palsies | 223 | ||
Meningitis | 223 | ||
Guillain–Barré syndrome and Miller Fisher variant | 224 | ||
Symptoms and signs | 224 | ||
Wernicke encephalopathy | 225 | ||
Brain disease | 225 | ||
Internuclear ophthalmoplegia (INO) | 225 | ||
Causes | 225 | ||
Mechanism (Fig. 5.21) | 225 | ||
Symptoms | 225 | ||
Signs | 226 | ||
Unilateral INO (Fig. 5.22) | 226 | ||
Bilateral INO (Video 5.16) | 227 | ||
Differential diagnosis | 227 | ||
Investigations | 227 | ||
Treatment | 227 | ||
Skew deviation | 227 | ||
Causes | 227 | ||
Symptoms | 227 | ||
Signs (Fig. 5.23, Video 5.17) | 227 | ||
Differential diagnosis | 228 | ||
Investigations | 228 | ||
Treatment | 228 | ||
Supranuclear ophthalmoplegias | 228 | ||
Dorsal midbrain syndrome | 229 | ||
Causes | 229 | ||
Mechanism | 229 | ||
Symptoms | 229 | ||
Signs (Fig. 5.24 and Video 5.18) | 230 | ||
Investigations | 230 | ||
Horizontal gaze palsy (Videos 5.19 and 5.20) | 230 | ||
Horizontal saccadic palsy | 231 | ||
6 “Seeing things” | 241 | ||
Contents | 241 | ||
Introduction | 242 | ||
Eye disease | 242 | ||
Optic nerve disease | 242 | ||
Brain disease | 242 | ||
Examination checklist | 243 | ||
“Seeing things” | 243 | ||
History | 243 | ||
Examination | 243 | ||
Plus: perform perimetry: | 244 | ||
Visual illusions (Table 6.1 and Fig. 6.1) | 245 | ||
Metamorphopsia (Fig. 6.2) | 246 | ||
7 Abnormal movement or orientation of the visual world | 253 | ||
Contents | 253 | ||
Introduction | 254 | ||
Inner ear disease | 254 | ||
Brain disease | 254 | ||
Types of eye movement disorders causing abnormal movement of the visual world | 255 | ||
Examination checklist | 255 | ||
Abnormal movement of the visual world | 255 | ||
History | 255 | ||
Examination | 256 | ||
Plus: perform perimetry if: | 256 | ||
Oscillopsia | 256 | ||
Definition | 256 | ||
Causes | 257 | ||
Acquired nystagmus | 257 | ||
Definition | 257 | ||
Types | 257 | ||
Common types of acquired nystagmus | 257 | ||
Central vestibular nystagmus | 257 | ||
Convergence retraction nystagmus (Video 7.16) | 258 | ||
See-saw nystagmus (Video 7.6) | 259 | ||
Periodic alternating nystagmus (Video 7.7) | 259 | ||
Acquired pendular nystagmus (Video 7.15) | 259 | ||
Rebound nystagmus (Videos 7.18 and 7.19) | 259 | ||
Voluntary nystagmus (Video 7.20) | 259 | ||
Saccadic intrusions | 259 | ||
Types and significance | 259 | ||
Square-wave jerks (Video 7.10) | 259 | ||
Macrosquare-wave jerks (Video 7.11) | 260 | ||
Macrosaccadic oscillations (Video 7.12) | 260 | ||
Opsoclonus (Video 7.13) | 260 | ||
Ocular flutter (Video 7.14) | 260 | ||
Superior oblique myokymia (Video 7.9) | 260 | ||
Abnormal vestibulo-ocular reflex | 260 | ||
Treatment of oscillopsia | 260 | ||
Akinetopsia | 261 | ||
Definition | 261 | ||
Types | 261 | ||
Etiology | 261 | ||
Testing | 261 | ||
Manifestations | 261 | ||
Associated deficits | 262 | ||
8 Abnormal eye movements without visual symptoms | 265 | ||
Contents | 265 | ||
Introduction | 266 | ||
Examination checklist | 266 | ||
Abnormal eye movements without visual symptoms | 266 | ||
History | 266 | ||
Examination | 267 | ||
Plus: perform perimetry if: | 267 | ||
Misaligned eyes without diplopia | 267 | ||
Poor vision or childhood-onset strabismus | 267 | ||
Abnormal voluntary eye movements without diplopia | 268 | ||
Normal age-related loss of upgaze | 268 | ||
Gaze palsy | 268 | ||
Horizontal gaze palsy | 268 | ||
Signs | 268 | ||
9 Unequal pupils | 275 | ||
Contents | 275 | ||
Introduction | 276 | ||
Iris disease | 276 | ||
Parasympathetic chain disease (brain, third nerve, ciliary ganglion) | 276 | ||
Sympathetic chain disease (brain, neck, upper chest) | 276 | ||
Examination checklist | 277 | ||
Unequal pupils | 277 | ||
History | 277 | ||
Examination | 277 | ||
Plus: perform perimetry if: | 278 | ||
Management flowchart | 279 | ||
Unequal pupils | 279 | ||
Approach to anisocoria | 280 | ||
Definition | 280 | ||
Etiology | 280 | ||
Rule | 280 | ||
Question | 280 | ||
Answer | 280 | ||
Explanation | 280 | ||
Anisocoria with normally reactive pupils | 280 | ||
Differential diagnosis | 280 | ||
Physiologic anisocoria (Fig. 9.1) | 280 | ||
Horner syndrome (Fig. 9.2 and Video 9.1) | 281 | ||
Signs | 281 | ||
Pharmacologic testing to confirm the diagnosis of Horner syndrome (Table 9.1) | 281 | ||
Causes | 284 | ||
Clinical clues to the location of the lesion | 285 | ||
Pharmacologic testing to determine the location of the lesion | 285 | ||
Investigations | 286 | ||
Intermittent unilateral pupillary mydriasis (sympathetic form) (Fig. 9.7) | 286 | ||
Anisocoria with one pupil that is poorly reactive or non-reactive to light | 287 | ||
Differential diagnosis | 287 | ||
Evaluation | 287 | ||
Iris sphincter damage (traumatic mydriasis) (Fig. 9.8) | 287 | ||
Pharmacologic blockade (Fig. 9.9) | 288 | ||
Topical parasympatholytic agents (causing dilated pupil/s) | 288 | ||
Topical parasympathomimetic agents (causing constricted pupil/s) | 289 | ||
Tonic pupil (Fig. 9.10 and Video 9.2) | 289 | ||
Signs | 289 | ||
Etiology | 289 | ||
Causes | 290 | ||
Pharmacologic testing for tonic pupil (Fig. 9.10) | 291 | ||
Third nerve palsy (Fig. 9.11) | 291 | ||
Intermittent unilateral pupillary mydriasis (parasympathetic form) (Fig. 9.12) | 292 | ||
10 Ptosis | 293 | ||
Contents | 293 | ||
Introduction | 294 | ||
Examination checklist | 294 | ||
Ptosis | 294 | ||
History | 294 | ||
Examination | 295 | ||
Management flowchart | 297 | ||
Aponeurotic ptosis | 298 | ||
Cause | 298 | ||
Demographic | 298 | ||
Symptoms | 298 | ||
Signs | 298 | ||
Investigations | 298 | ||
Treatment | 298 | ||
Caution | 298 | ||
Ptosis due to levator myopathy | 299 | ||
Causes | 299 | ||
Demographic | 299 | ||
Symptoms | 299 | ||
Signs | 299 | ||
Investigations | 299 | ||
Treatment | 299 | ||
Ptosis due to myasthenia gravis | 300 | ||
Demographic | 300 | ||
Symptoms and signs | 300 | ||
Investigations and treatment | 301 | ||
Ptosis due to partial third nerve palsy | 301 | ||
Caution | 301 | ||
Causes | 301 | ||
Demographic | 301 | ||
Symptoms and signs | 301 | ||
Investigations | 302 | ||
Treatment | 302 | ||
Ptosis due to Horner syndrome | 303 | ||
Causes | 303 | ||
Demographic | 303 | ||
Symptoms and signs | 303 | ||
Pharmacologic testing | 303 | ||
Investigations | 304 | ||
Treatment | 304 | ||
11 Facial weakness or spasm | 305 | ||
Contents | 305 | ||
Introduction | 306 | ||
Facial weakness | 306 | ||
Involuntary facial movements | 306 | ||
Examination checklist | 307 | ||
Facial weakness or spasm | 307 | ||
History | 307 | ||
Examination | 307 | ||
Facial weakness | 308 | ||
Facial nerve palsy | 308 | ||
Causes | 308 | ||
Symptoms and signs (Figs. 11.1 and 11.2, Video 11.1) | 308 | ||
Ophthalmic | 308 | ||
Other symptoms of facial nerve dysfunction | 308 | ||
Possible localizing symptoms and signs | 309 | ||
Differential diagnosis | 311 | ||
Investigations | 311 | ||
Ophthalmic complications | 311 | ||
Ophthalmic treatment | 311 | ||
Involuntary facial movements | 312 | ||
Orbicularis oculi myokymia | 312 | ||
12 Unexplained eye pain, orbital pain or headache | 317 | ||
Contents | 317 | ||
Introduction | 318 | ||
Examination checklist | 318 | ||
Unexplained eye pain or headache | 318 | ||
History | 318 | ||
Examination | 319 | ||
Ophthalmic causes of headache or facial pain | 319 | ||
Headache due to angle-closure glaucoma | 320 | ||
Headache due to herpes zoster ophthalmicus | 320 | ||
Headache due to refractive error | 320 | ||
Headache due to heterophoria or heterotropia | 320 | ||
Ophthalmic symptoms and signs of an intracranial or systemic cause of headache or facial pain | 320 | ||
Giant cell arteritis (GCA) | 321 | ||
Raised intracranial pressure | 321 | ||
Pituitary apoplexy | 322 | ||
Internal carotid artery (ICA) dissection | 322 | ||
Causes | 322 | ||
Symptoms and signs | 322 | ||
Investigations | 322 | ||
Treatment | 322 | ||
Trigeminal neuralgia | 322 | ||
Causes (Fig. 12.1) | 322 | ||
Symptoms | 323 | ||
Signs | 323 | ||
Investigations | 323 | ||
Treatment | 323 | ||
Common “benign” headache patterns with ophthalmic features | 324 | ||
Migraine | 324 | ||
Trigeminal autonomic cephalalgias (TACs) | 325 | ||
When to refer other patients for further investigation | 325 | ||
13 Neuro-ophthalmic history and examination | 327 | ||
Contents | 327 | ||
Introduction | 328 | ||
History | 328 | ||
Patient Details | 328 | ||
Presenting complaint | 328 | ||
Other ophthalmic symptoms | 329 | ||
Ophthalmic history | 329 | ||
Medical history | 329 | ||
Medications | 329 | ||
Family history | 329 | ||
Social and occupational history | 329 | ||
Symptoms of giant cell arteritis (GCA) | 330 | ||
Systems review questions | 330 | ||
General | 330 | ||
Neurologic | 330 | ||
Ear, nose, throat | 330 | ||
Respiratory | 330 | ||
Cardiovascular | 331 | ||
Gastrointestinal | 331 | ||
Genitourinary | 331 | ||
Musculoskeletal | 331 | ||
Skin | 331 | ||
Infectious risk factors | 331 | ||
Examination | 331 | ||
Visual acuity (VA) | 333 | ||
Color vision (Video 13.1) | 333 | ||
Subjective color desaturation (Fig. 13.1) | 333 | ||
Color plate tests (e.g. Ishihara or Hardy-Rand-Rittler pseudoisochromatic color plates) | 333 | ||
Visual fields to confrontation (Fig. 13.2 and Video 13.2) | 334 | ||
Descriptive | 335 | ||
Finger counting in quadrants | 335 | ||
Red target for central field | 335 | ||
Red target for hemianopic defect | 335 | ||
Perimetry | 336 | ||
Fixation, alignment and eye movements (Video 13.3) | 336 | ||
Suggested reading | 365 | ||
Appendix: Checklists | 367 | ||
Neuro-ophthalmic history checklist | 367 | ||
Neuro-ophthalmic examination checklist | 367 | ||
Index | 369 | ||
A | 369 | ||
B | 371 | ||
C | 371 | ||
D | 373 | ||
E | 374 | ||
F | 375 | ||
G | 376 | ||
H | 377 | ||
I | 378 | ||
J | 379 | ||
K | 379 | ||
L | 379 | ||
M | 380 | ||
N | 382 | ||
O | 383 | ||
P | 385 | ||
Q | 387 | ||
R | 387 | ||
S | 388 | ||
T | 389 | ||
U | 391 | ||
V | 391 | ||
W | 392 | ||
Z | 392 |